This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cryoport, Inc., the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, announced that Dr. Mark W. Sawicki, Chief Commercial Officer, will present at the 3rd Annual BioLogistics Summit in San Francisco, CA on Wednesday, July 15th, 2015, at 2:15 p.m. PT. Dr. Sawicki will discuss advanced logistics for both clinical samples and commercial finished goods of emerging cell and gene therapies.
The BioLogistics Summit is focused on regulatory compliance and quality operations and logistics for temperature-sensitive biologic materials and products for clinical and commercial supply chains. Many organizations strive to remain compliant with current GDP guidelines and struggle to efficiently anticipate forthcoming standards for the transportation of biologics on clinical and commercial supply chains. The Summit helps companies remain informed to accurately address domestic and international temperature-sensitive specialty supply chain challenges.
Dr. Mark Sawicki, Cryoport's Chief Commercial Officer, commented, "We are excited to participate in the 3(rd) Annual BioLogistics Summit, as it focuses on all of the drivers for our advanced cryogenic logistics solutions. The industry faces many challenges as organizations improve existing operations to streamline clinical trials or bring finished product to market under an ever stricter regulatory environment. Cryoport's globally validated cryogenic logistics solutions mitigate a company's concern for quality control and costly delays with a best-in-class network and chain-of-command capabilities."
A copy of the presentation will be accessible via the Resources section of the Company's website at www.cryoport.com for 60 days after the presentation.
>> For more information, click here
